# Avelo

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/avelo-2

- Industry: Medical Devices & Equipment
- Headquarters: Switzerland
- Website: www.avelolife.com
- Total disclosed funding: $2.2M
- Latest round: Seed (Sep 20, 2022)
- Investors on record: 4

## About

Based in Switzerland, and co-founded in 2020 by Melanie Aregger (CEO), Tobias Broger (CTO), Avelo Inc. is a manufacturer of clinical equipment for treating respiratory infections. In December 2023, Avelo Inc. received CHF 1.5 million of grant funding from Innosuisse - Swiss Innovation Agency.

The firm provides a breath aerosol medical device equipment, AveloCollect, that detects respiratory tract infections causing pneumonia. AveloCollect works with molecular tests and can be used in every healthcare setting. It also reduces over 65% of unnecessary antibiotic prescriptions in primary care by combining respiratory multiplex tests that distinguish between viral and bacterial illnesses.

The company plans to utilize the December 2023 funding to further develop its AveloCollect, a breath sampling device that diagnose lower respiratory tract infections.

## Funding rounds

- Seed, Sep 20, 2022, $2.2M — Zürcher Kantonalbank, Sanner Ventures, Privilege Ventures, Occident Group

## Investors

- Zürcher Kantonalbank — Seed
- Sanner Ventures (https://capitalatlas.ai/funds/sanner-ventures) — Seed
- Privilege Ventures (https://capitalatlas.ai/funds/privilege-ventures) — Seed
- Occident Group — Seed